LGVN

Longeveron Inc.

Healthcare · Biotechnology

$156.97 sample

-2.54 (-1.59%) 1D

Market cap

$756.3B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-13

Alerts

8

Price$156.97 +7.32% 3M daily closessample

159.51135.00

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13SECForm 144 filed
Oct 02SEC10-Q filed
Sep 24INSInsider sell: Chief Executive Officer
Sep 21INSInsider sell: 10% owner
Sep 14INSInsider buy: 10% owner
Sep 03SEC10-Q filed
Aug 31INSInsider buy: 10% owner
Aug 26INSInsider sell: Director

Sign up to see the real LGVN record →

Company facts

SEC EDGAR registration

Name: Longeveron Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -33sample, -100 to +100
Reporting currency: USD

Who is positioning in LGVN

sample

Insiders: 13 insider transactions over 90 days, net selling, $238.6M
Congress: No member trades over 90 days
Institutions · 13F: 39 funds hold $4.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$33.7B +11.1% y/y

Q4 2024Q3 2026

Inventory$20.3B +9.7% y/y

Q4 2024Q3 2026

Accounts receivable$15.4B +10.0% y/y

Q4 2024Q3 2026

Total debt$39.2B +11.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $612.6B +15.6% 3M
Sample peer B: $148.0B -9.5% 3M
Sample peer C: $563.3B -11.6% 3M
Sample peer D: $570.8B +13.5% 3M
Sample peer E: $528.7B +9.8% 3M